Our Experts in the News
-
'A hugely consequential decision:' How Biogen's Alzheimer's drug came to face the FDA
May 27, 2021
BioPharma Dive
-
Mind Game
May 23, 2021
Full Measure
-
Did the U.S. FDA Improperly Expedite Remdesivir’s Approval? The Public Citizen Demand Letter to FDA, Plus a TrialSite Perspective
May 22, 2021
TrialSite News
-
FDA reviewers: Why we are against approval of aducanumab for Alzheimer's
May 5, 2021
Medscape
-
Pfizer prepares to file for full FDA approval of its Covid vaccine
May 4, 2021
Financial Buzz
-
FDA is urged to move faster to list medicines withdrawn over safety concerns
April 14, 2021
STAT
-
In-Depth: How full FDA approval would impact vaccine mandates, competition
April 9, 2021
ABC-10 News, San Diego
-
Watchdog calls for probe into 'inappropriate' FDA-Biogen aducanumab collaboration
April 5, 2021
Fierce Biotech
-
FDA panels say new arthritis drug too risky
March 25, 2021
Pain News Network
-
Carcinogen found in hand sanitizers that plugged COVID gap
March 24, 2021
The Seattle Times
-
Pfizer hopes for a happy ending for an osteoarthritis drug with a troubled history
March 24, 2021
STAT
-
How the bitter political fight over painkillers could derail Biden's FDA pick
March 18, 2021
Politico
-
Policy Deciphered: Could FDA inspection backlog lead to approval slowdown?
March 11, 2021
Medical Marketing and Media
-
The Alzheimer's approval maze
March 11, 2021
pharma Manufacturing
-
Pandemic Forces F.D.A. to Sharply Curtail Drug Company Inspections
March 9, 2021
The New York Times
-
Alzheimer's Association Denies Conflict in Aducanumab Support
March 8, 2021
Medscape
-
Some retirement communities lure new residents with promise of Covid-19 vaccines
February 18, 2021
NBC News
-
Janet Woodcock slams calls for FDA 'firewall' amid aducanumab debacle, citing need for collaborative drug development
February 17, 2021
Endpoints News
-
After a controversial Alzheimer’s drug review, FDA’s Woodcock rejects proposal to ‘firewall’ agency review staff
February 16, 2021
STAT
-
Biogen Alzheimer’s Drug Puts FDA’s Judgment in Harsh Spotlight
January 30, 2021
Bloomberg
Login
Subscribe